Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Secondary Outcome: Secondary Outcomes: Changes in waist circumference, body fat, body lean mass, and metabolic risk factors including levels of plasma glucose, insulin sensitivity, serum lipids, and blood pressure Statistical Analysis Full details previously published 2 and can also be found in the STEP group statistical analysis plan at NEJM.org Statistical analysis approach sought strong control for type I error All endpoints addressing intervention efficacy were analyzed using intention-to-treat approach All endpoints addressing intervention safety were analyzed using per-protocol approach Efficacy endpoints analyzed using 2 estimands Treatment Policy Estimand: intention to treat analysis
Link to existing habits
How Klinic Handles Prior Authorization For all prescribed medications, including Zepbound prior authorization, Klinic tackles the entire authorization process
If additional glycemic control is needed: Increase to 9 mg orally once a day
The product on this page is manufactured by APX Peptide Labs, is not affiliated with or endorsed by Hospira or Pfizer, and is sold strictly as a laboratory research diluent not as a substitute for any FDA-approved injectable drug product
US$ 20.99
US$ 20.61
US$ 25.14
US$ 24.64
US$ 29.02
US$ 26.81
